\Monitor: Weight loss speed Protein intake Use cautiously in: Cancer cachexia Chronic infections such as TB / HIV when nutritional reserve is poor Renal disease Generally no dose adjustment required in CKD, but vomiting/dehydration can precipitate AKI Hepatic disease Generally safe
This review examines the biological mechanisms underlying GLP-1 RA therapy in MASLD/MASH, analyzes the mechanistic distinctions between mono-, dual-, and triple agonists, and synthesizes current clinical evidence supporting their utilization in individuals with this condition
Talk to your healthcare provider about the steps youve taken, such as changes to your diet, weight loss surgery, exercise habits, or behavior, and be honest about what hasnt worked
Maybe the power went out overnight
Possible Side Effects Side effects are uncommon but may include mild soreness at the injection site or a temporary headache
This investigational drug is distinctive in targeting GIP, GLP-1, and glucagon receptors, a novel approach compared to existing obesity treatments